 | • レポートコード：D0GIR-01062 • 出版社/出版日：GlobalInfoResearch / 2020年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、RNAベース治療・ワクチンの世界市場を広く調査・分析し、今後の市場展望をまとめております。RNAベース治療・ワクチンの種類別市場規模（RNAベース治療、RNAベースワクチン）、用途別市場規模（腫瘍学、免疫学、眼科、循環器疾患、感染症、遺伝病、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Alnylam Pharmaceuticals、Marina Biotech、BioNTech、Arbutus Biopharma、Regulus Therapeutics、Arrowhead Pharmaceuticals、Moderna Therapeutics、Dicerna Pharmaceuticals、CureVac、MiRagen Therapeutics、Quark Pharmaceuticals、Roche、Sylentis ・地域別グローバル市場分析 2015年-2020年 ・RNAベース治療・ワクチンの北米市場（アメリカ、カナダ、メキシコ） ・RNAベース治療・ワクチンのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・RNAベース治療・ワクチンのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・RNAベース治療・ワクチンの南米市場（ブラジル、アルゼンチン） ・RNAベース治療・ワクチンの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：RNAベース治療、RNAベースワクチン ・用途別分析：腫瘍学、免疫学、眼科、循環器疾患、感染症、遺伝病、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global RNA-Based Therapeutics and Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The RNA-Based Therapeutics and Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
RNA-Based Therapeutics and Vaccines market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, RNA-Based Therapeutics and Vaccines market has been segmented into:
RNA-Based Therapeutics
RNA-Based Vaccines
By Application, RNA-Based Therapeutics and Vaccines has been segmented into:
Oncology
Immunology
Ophthalmology
Cardiovascular Diseases
Infectious Diseases
Genetic Diseases
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global RNA-Based Therapeutics and Vaccines market presented in the report. This section sheds light on the sales growth of different regional and country-level RNA-Based Therapeutics and Vaccines markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global RNA-Based Therapeutics and Vaccines market.
The report offers in-depth assessment of the growth and other aspects of the RNA-Based Therapeutics and Vaccines market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and RNA-Based Therapeutics and Vaccines Market Share Analysis
RNA-Based Therapeutics and Vaccines competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, RNA-Based Therapeutics and Vaccines sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the RNA-Based Therapeutics and Vaccines sales, revenue and market share for each player covered in this report.
The major players covered in RNA-Based Therapeutics and Vaccines are:
Alnylam Pharmaceuticals
Marina Biotech
BioNTech
Arbutus Biopharma
Regulus Therapeutics
Arrowhead Pharmaceuticals
Moderna Therapeutics
Dicerna Pharmaceuticals
CureVac
MiRagen Therapeutics
Quark Pharmaceuticals
Roche
Sylentis
Table of Contents
1 RNA-Based Therapeutics and Vaccines Market Overview
1.1 Product Overview and Scope of RNA-Based Therapeutics and Vaccines
1.2 Classification of RNA-Based Therapeutics and Vaccines by Type
1.2.1 Global RNA-Based Therapeutics and Vaccines Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global RNA-Based Therapeutics and Vaccines Revenue Market Share by Type in 2019
1.2.3 RNA-Based Therapeutics
1.2.4 RNA-Based Vaccines
1.3 Global RNA-Based Therapeutics and Vaccines Market by Application
1.3.1 Overview: Global RNA-Based Therapeutics and Vaccines Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Oncology
1.3.3 Immunology
1.3.4 Ophthalmology
1.3.5 Cardiovascular Diseases
1.3.6 Infectious Diseases
1.3.7 Genetic Diseases
1.3.8 Others
1.4 Global RNA-Based Therapeutics and Vaccines Market by Regions
1.4.1 Global RNA-Based Therapeutics and Vaccines Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of RNA-Based Therapeutics and Vaccines (2015-2025)
1.4.3 North America (USA, Canada and Mexico) RNA-Based Therapeutics and Vaccines Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) RNA-Based Therapeutics and Vaccines Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) RNA-Based Therapeutics and Vaccines Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) RNA-Based Therapeutics and Vaccines Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) RNA-Based Therapeutics and Vaccines Status and Prospect (2015-2025)
2 Company Profiles
2.1 Alnylam Pharmaceuticals
2.1.1 Alnylam Pharmaceuticals Details
2.1.2 Alnylam Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Alnylam Pharmaceuticals SWOT Analysis
2.1.4 Alnylam Pharmaceuticals Product and Services
2.1.5 Alnylam Pharmaceuticals RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.2 Marina Biotech
2.2.1 Marina Biotech Details
2.2.2 Marina Biotech Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Marina Biotech SWOT Analysis
2.2.4 Marina Biotech Product and Services
2.2.5 Marina Biotech RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.3 BioNTech
2.3.1 BioNTech Details
2.3.2 BioNTech Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 BioNTech SWOT Analysis
2.3.4 BioNTech Product and Services
2.3.5 BioNTech RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.4 Arbutus Biopharma
2.4.1 Arbutus Biopharma Details
2.4.2 Arbutus Biopharma Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Arbutus Biopharma SWOT Analysis
2.4.4 Arbutus Biopharma Product and Services
2.4.5 Arbutus Biopharma RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.5 Regulus Therapeutics
2.5.1 Regulus Therapeutics Details
2.5.2 Regulus Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Regulus Therapeutics SWOT Analysis
2.5.4 Regulus Therapeutics Product and Services
2.5.5 Regulus Therapeutics RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.6 Arrowhead Pharmaceuticals
2.6.1 Arrowhead Pharmaceuticals Details
2.6.2 Arrowhead Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Arrowhead Pharmaceuticals SWOT Analysis
2.6.4 Arrowhead Pharmaceuticals Product and Services
2.6.5 Arrowhead Pharmaceuticals RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.7 Moderna Therapeutics
2.7.1 Moderna Therapeutics Details
2.7.2 Moderna Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Moderna Therapeutics SWOT Analysis
2.7.4 Moderna Therapeutics Product and Services
2.7.5 Moderna Therapeutics RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.8 Dicerna Pharmaceuticals
2.8.1 Dicerna Pharmaceuticals Details
2.8.2 Dicerna Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Dicerna Pharmaceuticals SWOT Analysis
2.8.4 Dicerna Pharmaceuticals Product and Services
2.8.5 Dicerna Pharmaceuticals RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.9 CureVac
2.9.1 CureVac Details
2.9.2 CureVac Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 CureVac SWOT Analysis
2.9.4 CureVac Product and Services
2.9.5 CureVac RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.10 MiRagen Therapeutics
2.10.1 MiRagen Therapeutics Details
2.10.2 MiRagen Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 MiRagen Therapeutics SWOT Analysis
2.10.4 MiRagen Therapeutics Product and Services
2.10.5 MiRagen Therapeutics RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.11 Quark Pharmaceuticals
2.11.1 Quark Pharmaceuticals Details
2.11.2 Quark Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Quark Pharmaceuticals SWOT Analysis
2.11.4 Quark Pharmaceuticals Product and Services
2.11.5 Quark Pharmaceuticals RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.12 Roche
2.12.1 Roche Details
2.12.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Roche SWOT Analysis
2.12.4 Roche Product and Services
2.12.5 Roche RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.13 Sylentis
2.13.1 Sylentis Details
2.13.2 Sylentis Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Sylentis SWOT Analysis
2.13.4 Sylentis Product and Services
2.13.5 Sylentis RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global RNA-Based Therapeutics and Vaccines Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 RNA-Based Therapeutics and Vaccines Players Market Share
3.2.2 Top 10 RNA-Based Therapeutics and Vaccines Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global RNA-Based Therapeutics and Vaccines Revenue and Market Share by Regions
4.2 North America RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2015-2020)
4.3 Europe RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2015-2020)
4.5 South America RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2015-2020)
5 North America RNA-Based Therapeutics and Vaccines Revenue by Countries
5.1 North America RNA-Based Therapeutics and Vaccines Revenue by Countries (2015-2020)
5.2 USA RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2015-2020)
5.3 Canada RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2015-2020)
5.4 Mexico RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2015-2020)
6 Europe RNA-Based Therapeutics and Vaccines Revenue by Countries
6.1 Europe RNA-Based Therapeutics and Vaccines Revenue by Countries (2015-2020)
6.2 Germany RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2015-2020)
6.3 UK RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2015-2020)
6.4 France RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2015-2020)
6.5 Russia RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2015-2020)
6.6 Italy RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2015-2020)
7 Asia-Pacific RNA-Based Therapeutics and Vaccines Revenue by Countries
7.1 Asia-Pacific RNA-Based Therapeutics and Vaccines Revenue by Countries (2015-2020)
7.2 China RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2015-2020)
7.3 Japan RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2015-2020)
7.4 Korea RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2015-2020)
7.5 India RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2015-2020)
8 South America RNA-Based Therapeutics and Vaccines Revenue by Countries
8.1 South America RNA-Based Therapeutics and Vaccines Revenue by Countries (2015-2020)
8.2 Brazil RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2015-2020)
8.3 Argentina RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue RNA-Based Therapeutics and Vaccines by Countries
9.1 Middle East & Africa RNA-Based Therapeutics and Vaccines Revenue by Countries (2015-2020)
9.2 Saudi Arabia RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2015-2020)
9.3 UAE RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2015-2020)
9.4 Egypt RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2015-2020)
9.5 South Africa RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global RNA-Based Therapeutics and Vaccines Revenue and Market Share by Type (2015-2020)
10.2 Global RNA-Based Therapeutics and Vaccines Market Forecast by Type (2019-2024)
10.3 RNA-Based Therapeutics Revenue Growth Rate (2015-2025)
10.4 RNA-Based Vaccines Revenue Growth Rate (2015-2025)
11 Global RNA-Based Therapeutics and Vaccines Market Segment by Application
11.1 Global RNA-Based Therapeutics and Vaccines Revenue Market Share by Application (2015-2020)
11.2 RNA-Based Therapeutics and Vaccines Market Forecast by Application (2019-2024)
11.3 Oncology Revenue Growth (2015-2020)
11.4 Immunology Revenue Growth (2015-2020)
11.5 Ophthalmology Revenue Growth (2015-2020)
11.6 Cardiovascular Diseases Revenue Growth (2015-2020)
11.7 Infectious Diseases Revenue Growth (2015-2020)
11.8 Genetic Diseases Revenue Growth (2015-2020)
11.9 Others Revenue Growth (2015-2020)
12 Global RNA-Based Therapeutics and Vaccines Market Size Forecast (2021-2025)
12.1 Global RNA-Based Therapeutics and Vaccines Market Size Forecast (2021-2025)
12.2 Global RNA-Based Therapeutics and Vaccines Market Forecast by Regions (2021-2025)
12.3 North America RNA-Based Therapeutics and Vaccines Revenue Market Forecast (2021-2025)
12.4 Europe RNA-Based Therapeutics and Vaccines Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific RNA-Based Therapeutics and Vaccines Revenue Market Forecast (2021-2025)
12.6 South America RNA-Based Therapeutics and Vaccines Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa RNA-Based Therapeutics and Vaccines Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global RNA-Based Therapeutics and Vaccines Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of RNA-Based Therapeutics and Vaccines by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global RNA-Based Therapeutics and Vaccines Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market RNA-Based Therapeutics and Vaccines Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Alnylam Pharmaceuticals Corporate Information, Location and Competitors
Table 6. Alnylam Pharmaceuticals RNA-Based Therapeutics and Vaccines Major Business
Table 7. Alnylam Pharmaceuticals RNA-Based Therapeutics and Vaccines Total Revenue (USD Million) (2017-2018)
Table 8. Alnylam Pharmaceuticals SWOT Analysis
Table 9. Alnylam Pharmaceuticals RNA-Based Therapeutics and Vaccines Product and Solutions
Table 10. Alnylam Pharmaceuticals RNA-Based Therapeutics and Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Marina Biotech Corporate Information, Location and Competitors
Table 12. Marina Biotech RNA-Based Therapeutics and Vaccines Major Business
Table 13. Marina Biotech RNA-Based Therapeutics and Vaccines Total Revenue (USD Million) (2018-2019)
Table 14. Marina Biotech SWOT Analysis
Table 15. Marina Biotech RNA-Based Therapeutics and Vaccines Product and Solutions
Table 16. Marina Biotech RNA-Based Therapeutics and Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. BioNTech Corporate Information, Location and Competitors
Table 18. BioNTech RNA-Based Therapeutics and Vaccines Major Business
Table 19. BioNTech RNA-Based Therapeutics and Vaccines Total Revenue (USD Million) (2017-2018)
Table 20. BioNTech SWOT Analysis
Table 21. BioNTech RNA-Based Therapeutics and Vaccines Product and Solutions
Table 22. BioNTech RNA-Based Therapeutics and Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Arbutus Biopharma Corporate Information, Location and Competitors
Table 24. Arbutus Biopharma RNA-Based Therapeutics and Vaccines Major Business
Table 25. Arbutus Biopharma RNA-Based Therapeutics and Vaccines Total Revenue (USD Million) (2017-2018)
Table 26. Arbutus Biopharma SWOT Analysis
Table 27. Arbutus Biopharma RNA-Based Therapeutics and Vaccines Product and Solutions
Table 28. Arbutus Biopharma RNA-Based Therapeutics and Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Regulus Therapeutics Corporate Information, Location and Competitors
Table 30. Regulus Therapeutics RNA-Based Therapeutics and Vaccines Major Business
Table 31. Regulus Therapeutics RNA-Based Therapeutics and Vaccines Total Revenue (USD Million) (2017-2018)
Table 32. Regulus Therapeutics SWOT Analysis
Table 33. Regulus Therapeutics RNA-Based Therapeutics and Vaccines Product and Solutions
Table 34. Regulus Therapeutics RNA-Based Therapeutics and Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Arrowhead Pharmaceuticals Corporate Information, Location and Competitors
Table 36. Arrowhead Pharmaceuticals RNA-Based Therapeutics and Vaccines Major Business
Table 37. Arrowhead Pharmaceuticals RNA-Based Therapeutics and Vaccines Total Revenue (USD Million) (2017-2018)
Table 38. Arrowhead Pharmaceuticals SWOT Analysis
Table 39. Arrowhead Pharmaceuticals RNA-Based Therapeutics and Vaccines Product and Solutions
Table 40. Arrowhead Pharmaceuticals RNA-Based Therapeutics and Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Moderna Therapeutics Corporate Information, Location and Competitors
Table 42. Moderna Therapeutics RNA-Based Therapeutics and Vaccines Major Business
Table 43. Moderna Therapeutics RNA-Based Therapeutics and Vaccines Total Revenue (USD Million) (2017-2018)
Table 44. Moderna Therapeutics SWOT Analysis
Table 45. Moderna Therapeutics RNA-Based Therapeutics and Vaccines Product and Solutions
Table 46. Moderna Therapeutics RNA-Based Therapeutics and Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Dicerna Pharmaceuticals Corporate Information, Location and Competitors
Table 48. Dicerna Pharmaceuticals RNA-Based Therapeutics and Vaccines Major Business
Table 49. Dicerna Pharmaceuticals RNA-Based Therapeutics and Vaccines Total Revenue (USD Million) (2017-2018)
Table 50. Dicerna Pharmaceuticals SWOT Analysis
Table 51. Dicerna Pharmaceuticals RNA-Based Therapeutics and Vaccines Product and Solutions
Table 52. Dicerna Pharmaceuticals RNA-Based Therapeutics and Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. CureVac Corporate Information, Location and Competitors
Table 54. CureVac RNA-Based Therapeutics and Vaccines Major Business
Table 55. CureVac RNA-Based Therapeutics and Vaccines Total Revenue (USD Million) (2017-2018)
Table 56. CureVac SWOT Analysis
Table 57. CureVac RNA-Based Therapeutics and Vaccines Product and Solutions
Table 58. CureVac RNA-Based Therapeutics and Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. MiRagen Therapeutics Corporate Information, Location and Competitors
Table 60. MiRagen Therapeutics RNA-Based Therapeutics and Vaccines Major Business
Table 61. MiRagen Therapeutics RNA-Based Therapeutics and Vaccines Total Revenue (USD Million) (2017-2018)
Table 62. MiRagen Therapeutics SWOT Analysis
Table 63. MiRagen Therapeutics RNA-Based Therapeutics and Vaccines Product and Solutions
Table 64. MiRagen Therapeutics RNA-Based Therapeutics and Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Quark Pharmaceuticals Corporate Information, Location and Competitors
Table 66. Quark Pharmaceuticals RNA-Based Therapeutics and Vaccines Major Business
Table 67. Quark Pharmaceuticals RNA-Based Therapeutics and Vaccines Total Revenue (USD Million) (2017-2018)
Table 68. Quark Pharmaceuticals SWOT Analysis
Table 69. Quark Pharmaceuticals RNA-Based Therapeutics and Vaccines Product and Solutions
Table 70. Quark Pharmaceuticals RNA-Based Therapeutics and Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Roche Corporate Information, Location and Competitors
Table 72. Roche RNA-Based Therapeutics and Vaccines Major Business
Table 73. Roche RNA-Based Therapeutics and Vaccines Total Revenue (USD Million) (2017-2018)
Table 74. Roche SWOT Analysis
Table 75. Roche RNA-Based Therapeutics and Vaccines Product and Solutions
Table 76. Roche RNA-Based Therapeutics and Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Sylentis Corporate Information, Location and Competitors
Table 78. Sylentis RNA-Based Therapeutics and Vaccines Major Business
Table 79. Sylentis RNA-Based Therapeutics and Vaccines Total Revenue (USD Million) (2017-2018)
Table 80. Sylentis SWOT Analysis
Table 81. Sylentis RNA-Based Therapeutics and Vaccines Product and Solutions
Table 82. Sylentis RNA-Based Therapeutics and Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Global RNA-Based Therapeutics and Vaccines Revenue (Million USD) by Players (2015-2020)
Table 84. Global RNA-Based Therapeutics and Vaccines Revenue Share by Players (2015-2020)
Table 85. Global RNA-Based Therapeutics and Vaccines Revenue (Million USD) by Regions (2015-2020)
Table 86. Global RNA-Based Therapeutics and Vaccines Revenue Market Share by Regions (2015-2020)
Table 87. North America RNA-Based Therapeutics and Vaccines Revenue by Countries (2015-2020)
Table 88. North America RNA-Based Therapeutics and Vaccines Revenue Market Share by Countries (2015-2020)
Table 89. Europe RNA-Based Therapeutics and Vaccines Revenue (Million USD) by Countries (2015-2020)
Table 90. Asia-Pacific RNA-Based Therapeutics and Vaccines Revenue (Million USD) by Countries (2015-2020)
Table 91. South America RNA-Based Therapeutics and Vaccines Revenue by Countries (2015-2020)
Table 92. South America RNA-Based Therapeutics and Vaccines Revenue Market Share by Countries (2015-2020)
Table 93. Middle East and Africa RNA-Based Therapeutics and Vaccines Revenue (Million USD) by Countries (2015-2020)
Table 94. Middle East and Africa RNA-Based Therapeutics and Vaccines Revenue Market Share by Countries (2015-2020)
Table 95. Global RNA-Based Therapeutics and Vaccines Revenue (Million USD) by Type (2015-2020)
Table 96. Global RNA-Based Therapeutics and Vaccines Revenue Share by Type (2015-2020)
Table 97. Global RNA-Based Therapeutics and Vaccines Revenue Forecast by Type (2021-2025)
Table 98. Global RNA-Based Therapeutics and Vaccines Revenue by Application (2015-2020)
Table 99. Global RNA-Based Therapeutics and Vaccines Revenue Share by Application (2015-2020)
Table 100. Global RNA-Based Therapeutics and Vaccines Revenue Forecast by Application (2021-2025)
Table 101. Global RNA-Based Therapeutics and Vaccines Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. RNA-Based Therapeutics and Vaccines Picture
Figure 2. Global RNA-Based Therapeutics and Vaccines Revenue Market Share by Type in 2019
Figure 3. RNA-Based Therapeutics Picture
Figure 4. RNA-Based Vaccines Picture
Figure 5. RNA-Based Therapeutics and Vaccines Revenue Market Share by Application in 2019
Figure 6. Oncology Picture
Figure 7. Immunology Picture
Figure 8. Ophthalmology Picture
Figure 9. Cardiovascular Diseases Picture
Figure 10. Infectious Diseases Picture
Figure 11. Genetic Diseases Picture
Figure 12. Others Picture
Figure 13. Global RNA-Based Therapeutics and Vaccines Revenue (USD Million) and Growth Rate (2015-2025)
Figure 14. North America RNA-Based Therapeutics and Vaccines Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Europe RNA-Based Therapeutics and Vaccines Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Asia-Pacific RNA-Based Therapeutics and Vaccines Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. South America RNA-Based Therapeutics and Vaccines Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Middle East and Africa RNA-Based Therapeutics and Vaccines Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global RNA-Based Therapeutics and Vaccines Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Global RNA-Based Therapeutics and Vaccines Revenue Share by Players in 2019
Figure 21. Global Top 5 Players RNA-Based Therapeutics and Vaccines Revenue Market Share in 2019
Figure 22. Global Top 10 Players RNA-Based Therapeutics and Vaccines Revenue Market Share in 2019
Figure 23. Key Players Market Share Trend
Figure 24. Global RNA-Based Therapeutics and Vaccines Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 25. Global RNA-Based Therapeutics and Vaccines Revenue Market Share by Regions (2015-2020)
Figure 26. Global RNA-Based Therapeutics and Vaccines Revenue Market Share by Regions in 2018
Figure 27. North America RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2015-2020)
Figure 28. Europe RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2015-2020)
Figure 29. Asia-Pacific RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2015-2020)
Figure 30. South America RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2015-2020)
Figure 31. Middle East and Africa RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2015-2020)
Figure 32. North America RNA-Based Therapeutics and Vaccines Revenue Market Share by Countries (2015-2020)
Figure 33. North America RNA-Based Therapeutics and Vaccines Revenue Market Share by Countries in 2019
Figure 34. USA RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2015-2020)
Figure 35. Canada RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2015-2020)
Figure 36. Mexico RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2015-2020)
Figure 37. Europe RNA-Based Therapeutics and Vaccines Revenue Market Share by Countries (2015-2020)
Figure 38. Europe RNA-Based Therapeutics and Vaccines Revenue Market Share by Countries in 2019
Figure 39. Germany RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2015-2020)
Figure 40. UK RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2015-2020)
Figure 41. France RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2015-2020)
Figure 42. Russia RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2015-2020)
Figure 43. Italy RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2015-2020)
Figure 44. Asia-Pacific RNA-Based Therapeutics and Vaccines Revenue Market Share by Countries (2015-2020)
Figure 45. Asia-Pacific RNA-Based Therapeutics and Vaccines Revenue Market Share by Countries in 2019
Figure 46. China RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2015-2020)
Figure 47. Japan RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2015-2020)
Figure 48. Korea RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2015-2020)
Figure 49. India RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2015-2020)
Figure 50. Southeast Asia RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2015-2020)
Figure 51. South America RNA-Based Therapeutics and Vaccines Revenue Market Share by Countries (2015-2020)
Figure 52. South America RNA-Based Therapeutics and Vaccines Revenue Market Share by Countries in 2019
Figure 53. Brazil RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2015-2020)
Figure 54. Argentina RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2015-2020)
Figure 55. Middle East and Africa RNA-Based Therapeutics and Vaccines Revenue Market Share by Countries (2015-2020)
Figure 56. Middle East and Africa RNA-Based Therapeutics and Vaccines Revenue Market Share by Countries in 2019
Figure 57. Saudi Arabia RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2015-2020)
Figure 58. UAE RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2015-2020)
Figure 59. Egypt RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2015-2020)
Figure 60. South Africa RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2015-2020)
Figure 61. Global RNA-Based Therapeutics and Vaccines Revenue Share by Type (2015-2020)
Figure 62. Global RNA-Based Therapeutics and Vaccines Revenue Share by Type in 2019
Figure 63. Global RNA-Based Therapeutics and Vaccines Market Share Forecast by Type (2021-2025)
Figure 64. Global RNA-Based Therapeutics Revenue Growth Rate (2015-2020)
Figure 65. Global RNA-Based Vaccines Revenue Growth Rate (2015-2020)
Figure 66. Global RNA-Based Therapeutics and Vaccines Revenue Share by Application (2015-2020)
Figure 67. Global RNA-Based Therapeutics and Vaccines Revenue Share by Application in 2019
Figure 68. Global RNA-Based Therapeutics and Vaccines Market Share Forecast by Application (2021-2025)
Figure 69. Global Oncology Revenue Growth Rate (2015-2020)
Figure 70. Global Immunology Revenue Growth Rate (2015-2020)
Figure 71. Global Ophthalmology Revenue Growth Rate (2015-2020)
Figure 72. Global Cardiovascular Diseases Revenue Growth Rate (2015-2020)
Figure 73. Global Infectious Diseases Revenue Growth Rate (2015-2020)
Figure 74. Global Genetic Diseases Revenue Growth Rate (2015-2020)
Figure 75. Global Others Revenue Growth Rate (2015-2020)
Figure 76. Global RNA-Based Therapeutics and Vaccines Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 77. Global RNA-Based Therapeutics and Vaccines Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 78. Global RNA-Based Therapeutics and Vaccines Revenue Market Share Forecast by Regions (2021-2025)
Figure 79. North America RNA-Based Therapeutics and Vaccines Revenue Market Forecast (2021-2025)
Figure 80. Europe RNA-Based Therapeutics and Vaccines Revenue Market Forecast (2021-2025)
Figure 81. Asia-Pacific RNA-Based Therapeutics and Vaccines Revenue Market Forecast (2021-2025)
Figure 82. South America RNA-Based Therapeutics and Vaccines Revenue Market Forecast (2021-2025)
Figure 83. Middle East and Africa RNA-Based Therapeutics and Vaccines Revenue Market Forecast (2021-2025)
Figure 84. Sales Channel: Direct Channel vs Indirect Channel
mRNA癌ワクチン及び治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The mRNA Cancer Vaccines and Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value cha…- HIVワクチンの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global HIV Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The HIV Vaccines market report provi…
- 獣医用ワクチンの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Veterinary Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.7% in the forecast period of 2020 to 2025 and will expected to reach USD 8925.5 million by 2025, from USD 6886.4 million in 2019. The Veterinary Vacci…
- オリゴヌクレオチドベース治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Oligonucleotide-based Therapies market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opt…
- DPTワクチンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global DPT Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The DPT Vaccines market report provi…